Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?-Reference-Cited by-同舟云学术

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

Published:2009-12 Issue:12 Volume:18 Page:1176-1184
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

TrifirÃ² Gianluca,Pariente Antoine,Coloma Preciosa M.,Kors Jan A.,Polimeni Giovanni,Miremont-SalamÃ© Ghada,Catania Maria Antonietta,Salvo Francesco,David Anaelle,Moore Nicholas,Caputi Achille Patrizio,Sturkenboom Miriam,Molokhia Mariam,Hippisley-Cox Julia,Acedo Carlos Diaz,van der Lei Johan,Fourrier-Reglat Annie,

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference52 articles.

1. Assessing the impact of drug safety signals from the WHO database presented in âSIGNALâ: results from a questionnaire of National Pharmacovigilance Centres;StÃ¥hl;Drug Saf,2003

2. The Uppsala Monitoring Centre. Practical Pharmacovigilance. Signal Definition. http://www.who-umc.org/DynPage.aspx?id=22676#signaldef (accessed on 5 February 2009).

3. The role of databases in drug postmarketing surveillance;Rodriguez;Pharmacoepidemiol Drug Saf,2001

4. Signal selection and follow-up in pharmacovigilance;Meyboom;Drug Saf,2002

5. Evaluating drug effects in the post-Vioxx world: there must be a better way;Avorn;Circulation,2006

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System;Pharmaceuticals;2024-03-10

2. Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study;Drug Safety;2023-10-07

3. Safety Signal Evaluation of a Risk of Syncope and Dizziness Not Related to Bleeding or Stroke in Direct Oral Anticoagulant–treated Patients;Clinical Therapeutics;2023-01

4. ANALYSIS FOR HEART DISEASE PREDICTION USING DEEP NEURAL NETWORK AND VGG_19 CONVOLUTION NEURAL NETWORK;INT J IND ENG-THEORY;2023

5. A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting;Expert Opinion on Drug Safety;2022-09-01